Kyocera Corporation on Friday announced that its subsidiary, Kyocera Communication Systems Co., Ltd. (KCCS) has started joint research with the University of Tsukuba to develop an Artificial Intelligence (AI) system capable of detecting melanoma and other skin diseases by analyzing digital images of a patient's skin, and aims to commercialize the technology by 2020.
Recent developments in AI, image recognition, and IT infrastructure are facilitating great advances in the ability to analyze digital images. In the medical field, where digital imaging is already an essential diagnostic tool, AI-based image recognition offers revolutionary potential. Diagnosing skin diseases from digital images using AI will offer great advantages over conventional practices, which now often depend on the knowledge and experience of a physician.
In Japan, the number of skin cancer patients has approximately doubled from 1999 through 2014. Japan's Ministry of Health, Labour and Welfare has identified AI as a key technology in the healthcare and medical sector. Because skin cancer treatment outcomes are substantially improved by early diagnosis, better diagnostic technologies are in great demand.
KCCS is working with Professor Manabu Fujimoto and Assistant Professor Yasuhiro Fujisawa, both from the Department of Dermatology, Faculty of Medicine, University of Tsukuba, to develop an image-recognition system accurate enough to distinguish several types of skin malignancies, including melanoma. The next phase of their project will aim for image-based diagnostic support of any skin disease.
In addition to helping dermatology specialists, AI-based image recognition could allow accurate diagnoses in rural and remote areas lacking a local clinician, using pictures from smartphones or digital cameras to greatly improve healthcare outcomes.
KCCS will bring unique AI-based image-processing expertise accumulated through Labellio - a cloud-based web service. The service allows any user to create a simple "drag-and-drop" image classifier powered by deep learning.
KCCS and the University of Tsukuba will conduct joint research through March 2018, aiming toward a commercial application in the fiscal year ending March 2020. Furthermore, they plan to develop a system capable of identifying more than 2,000 different skin diseases from digital images by combining their respective resources and expertise in the future.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
